Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 25.0 | 73 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 67.5 | 66 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 80.0 | 75 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 83.5 | 92 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 79.0 | 62 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 75.0 | 94 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 80.0 | 63 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 73.0 | 57 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | IFN-g | 71.0 | 83 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 84.5 | 76 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 95.0 | 75 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 67.0 | 66 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 74.0 | 77 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 83.0 | 71 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 84.0 | 83 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 75.5 | 82 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 94.0 | 97 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 106.0 | 66 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | IFN-g | 122.0 | 79 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 93.0 | 69 | |
N2759 | TNF-a | 100 | ng/mL | 3 | IFN-g | 101.0 | 86 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 107.0 | 93 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | IFN-g | 119.0 | 66 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IFN-g | 113.0 | 73 | |
N2586 | TNF-a | 100 | ng/mL | 3 | IFN-g | 111.5 | 68 |